From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

A functional map of more than 13,000 KCNQ1 variants has given researchers better understanding of those involved with long QT syndrome pathogenesis.

Microscopic traces of cancer in the bloodstream can identify patients who are high risk of their cancer returning, research suggests.

Digital twins of individual immune systems have identified a combination of two common drugs that could prevent premature birth.

New research reveals how autoimmune kidney inflammation develops and identifies an antibody-based strategy that may prevent ...

Kiszala, the CEO and co-founder of intoDNA, to explore how a breakthrough in understanding DNA damage and repair could ...

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.

The U.K. biotech IMU Biosciences will help create a large and detailed immune dataset for 80,000 people in the UK Biobank.

GLP-1 medications may reduce complications after surgery, with new research linking their use to fewer cardiovascular events ...

Eric Easom is the co-founder and CEO of AN2 Therapeutics, a biopharmaceutical company developing small molecule therapies using its boron chemistry platform. Prior to co-founding AN2, Easom was part ...

Clinical trials are generating increasingly large amounts of data, but companies are under immense pressure to complete trials quickly and under budget. Could agentic artificial intelligence (AI) be ...